PRHSX vs. PRGTX
Compare and contrast key facts about T. Rowe Price Health Sciences Fund (PRHSX) and T. Rowe Price Global Technology Fund (PRGTX).
PRHSX is managed by T. Rowe Price. It was launched on Dec 29, 1995. PRGTX is managed by T. Rowe Price. It was launched on Sep 28, 2000.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PRHSX or PRGTX.
Key characteristics
| PRHSX | PRGTX | |
|---|---|---|
| YTD Return | 11.44% | 34.14% |
| 1Y Return | 16.52% | 45.37% |
| 3Y Return (Ann) | -4.77% | -16.18% |
| 5Y Return (Ann) | 4.34% | 6.50% |
| 10Y Return (Ann) | 3.06% | 2.72% |
| Sharpe Ratio | 1.22 | 2.01 |
| Sortino Ratio | 1.65 | 2.61 |
| Omega Ratio | 1.23 | 1.35 |
| Calmar Ratio | 0.62 | 0.75 |
| Martin Ratio | 5.96 | 9.07 |
| Ulcer Index | 2.93% | 4.97% |
| Daily Std Dev | 14.25% | 22.43% |
| Max Drawdown | -47.79% | -73.10% |
| Current Drawdown | -16.37% | -42.00% |
Correlation
The correlation between PRHSX and PRGTX is 0.67, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
PRHSX vs. PRGTX - Performance Comparison
In the year-to-date period, PRHSX achieves a 11.44% return, which is significantly lower than PRGTX's 34.14% return. Over the past 10 years, PRHSX has outperformed PRGTX with an annualized return of 3.06%, while PRGTX has yielded a comparatively lower 2.72% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
PRHSX vs. PRGTX - Expense Ratio Comparison
PRHSX has a 0.80% expense ratio, which is lower than PRGTX's 0.95% expense ratio.
Risk-Adjusted Performance
PRHSX vs. PRGTX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Sciences Fund (PRHSX) and T. Rowe Price Global Technology Fund (PRGTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
PRHSX vs. PRGTX - Dividend Comparison
Neither PRHSX nor PRGTX has paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PRHSX T. Rowe Price Health Sciences Fund | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PRGTX T. Rowe Price Global Technology Fund | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.08% |
Drawdowns
PRHSX vs. PRGTX - Drawdown Comparison
The maximum PRHSX drawdown since its inception was -47.79%, smaller than the maximum PRGTX drawdown of -73.10%. Use the drawdown chart below to compare losses from any high point for PRHSX and PRGTX. For additional features, visit the drawdowns tool.
Volatility
PRHSX vs. PRGTX - Volatility Comparison
The current volatility for T. Rowe Price Health Sciences Fund (PRHSX) is 4.15%, while T. Rowe Price Global Technology Fund (PRGTX) has a volatility of 6.11%. This indicates that PRHSX experiences smaller price fluctuations and is considered to be less risky than PRGTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.